Day Zero Diagnostics
Solution Type
Diagnostics, Antimicrobial Stewardship
Pathogens Addressed
Bacteria, Fungi
Sectors Served
Human Health
Overview
Day Zero Diagnostics is a Boston-based infectious disease diagnostics company, acquired by bioMérieux in 2025. Its whole-genome sequencing platform identifies both the infecting pathogen and its full antibiotic resistance profile directly from clinical samples in hours , bypassing culture-based methods that take days, enabling physicians to prescribe the right antibiotic from the first day of hospital admission.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
